Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

EBioMedicine

Genetic validation of a role of NK3R antagonists in IHD suggests their consideration as a new means of preventing IHD in men. Whether they protect against prostate cancer might bear further consideration.

  • 123456 Profile photo of Madelyn

    Mendelian analysis of NKR3 antagonist function on heart disease risk in men. Future therapies? Lower testosterone, implications?